EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Outcomes of RDAVR with Coronary Revascularization: 3-year Results from the German INCA Registry

Aristidis Lenos, Justus T Strauch, Markus Schlömicher, Felix Fleissner, Diana M Valencia-Nunez, Jens Garbade, Roman Gottardi, Parwis Massoudy iD, Markus Kamler, Rizwan Malik, Gerhard Wimmer-Greinecker, Thomas Walther und 3 weitere

The Thoracic and Cardiovascular Surgeon · 01.04.2026 · 74 (03) · 199-209

DOI: 10.1055/a-2508-0732 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.04.2026. Verfasst von Aristidis Lenos und 14 weiteren Autor:innen. Beteiligte Einrichtung: Rhön Klinikum Campus Bad Neustadt, Bad Neustadt, Bayern, Germany. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Aortic Valve, Heart Valve Prosthesis Implantation, Coronary Artery Disease. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Edwards Lifesciences (Nyon, Switzerland).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The long-term outcomes of combined rapid-deployment aortic valve replacement (RDAVR) with coronary artery bypass graft surgery (CABG) are not well explored. We report 3-year results from the INCA registry on combined RDAVR with CABG.

Methods

INCA is a prospective, multicenter registry that enrolled 224 patients undergoing RDAVR with CABG at 10 cardiac institutions in Germany. Prosthetic valve hemodynamics, clinical outcomes, and quality of life (QoL) up to 3 years were assessed.

Results

The mean age of patients was 73.6 ± 6.1 years, and the mean logistic EuroSCORE was 7.8 ± 6.0%. The mean number of distal arterial and venous anastomoses was 3.13 ± 1.56, aortic cross-clamp time was 79.4 ± 24.1 minutes, cardiopulmonary bypass time was 109.6 ± 34.5 minutes, and operation time was 224.2 ± 62.7 minutes. The majority of implanted valve size was 25 mm. At baseline, 11 patients (4.9.%) had a permanent pacemaker. Postoperatively, 17 patients (7.6%) required a new pacemaker implantation (5.4% valve-related). All-cause mortality at 30 days was 2.2%, and 11.2% at 3 years. Patient QoL (SF-12v2) was significantly restored and maintained for up to 3 years (p < 0.001). Five patients (0.9%) underwent reoperation related to endocarditis. The postimplant mean gradient was 9.2 ± 3.7 at discharge and 8.9 ± 4.6 mm Hg at 3 years.

Conclusion

Combined RDAVR with CABG procedure is safe and effective over time. It offers stable and low transvalvular gradients with satisfactory clinical outcomes at 3 years. The pacemaker rate appears to be slightly increased, with no significant clinical effect at 3 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery BypassAortic ValveHeart Valve Prosthesis ImplantationCoronary Artery DiseaseAortic Valve StenosisHumansRegistriesMaleGermanyAgedFemaleTreatment OutcomeTime FactorsProspective StudiesQuality of LifeHeart Valve ProsthesisRisk FactorsMiddle AgedAged, 80 and overPostoperative ComplicationsProsthesis DesignHemodynamicsRecovery of Function

Autor:innen und Institutionen

  • Rhön Klinikum Campus Bad Neustadt, Bad Neustadt, Bayern, Germany.
  • Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum, Nordrhein-Westfalen, Germany.
  • Universitätsklinikum Düsseldorf, Dusseldorf, Nordrhein-Westfalen, Germany.
  • Klinikum Links der Weser gGmbH, Bremen, Bremen, German.
  • Department of Cardiac and Vascular Surgery, Universitäts-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Baden-Württemberg, Germany.
  • Department of Cardiac Surgery, Klinikum Passau, Passau, Germany.

ORCID-Profile: Parwis Massoudy, Peter Bramlage

Förderung

  • Edwards Lifesciences (Nyon, Switzerland)

Zitieren

APA

Lenos, A., Strauch, J. T., Schlömicher, M., Fleissner, F., Valencia-Nunez, D. M., Garbade, J., Gottardi, R., Massoudy, P., Kamler, M., Malik, R., Wimmer-Greinecker, G., Walther, T., Gummert, J., Bramlage, P., & Diegeler, A. (2026). Outcomes of RDAVR with Coronary Revascularization: 3-year Results from the German INCA Registry. The Thoracic and Cardiovascular Surgeon, 74(03), 199-209. https://doi.org/10.1055/a-2508-0732

Vancouver

Lenos A, Strauch JT, Schlömicher M, Fleissner F, Valencia-Nunez DM, Garbade J, et al. Outcomes of RDAVR with Coronary Revascularization: 3-year Results from the German INCA Registry. The Thoracic and Cardiovascular Surgeon. 2026;74(03):199-209. doi:10.1055/a-2508-0732

BibTeX
@article{Lenos2026,
  author = {Lenos, Aristidis and Strauch, Justus T and Schlömicher, Markus and Fleissner, Felix and Valencia-Nunez, Diana M and Garbade, Jens and Gottardi, Roman and Massoudy, Parwis and Kamler, Markus and Malik, Rizwan and Wimmer-Greinecker, Gerhard and Walther, Thomas and Gummert, Jan and Bramlage, Peter and Diegeler, Anno},
  title = {Outcomes of RDAVR with Coronary Revascularization: 3-year Results from the German INCA Registry},
  journal = {The Thoracic and Cardiovascular Surgeon},
  year = {2026},
  volume = {74},
  number = {03},
  pages = {199--209},
  doi = {10.1055/a-2508-0732}
}
Kostenlos starten →